The landscape of dementia diagnosis has evolved drastically with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades right before signs or symptoms emerge. While these technological innovations characterize impressive progress in being familiar with neurodegenerative disorders, https://wilhelms752pzi2.blogdosaga.com/profile